WST

— Fundamental Stock Analysis and Report Card

Healthcare : Medical - Instruments & Supplies

Located in Exton, PA, US. West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.

Growth

Revenue, earnings and profitability.

Strong revenue growth and earnings can attract investors, driving the stock price up. Profitability indicates the company's efficiency and sustainability, which impacts investor confidence. Poor performance in these areas can lead to a decrease in stock price.

Revenue History

Earnings History

Margins

Gross Margin TTM
36.24%
EBITDA Margin TTM
26.20%
Net Margin TTM
16.85%
Earnings Per Share TTM
7.54
Statements

Income & Cash Flow analysis.

An income statement shows what a company earned and spent over a period — revenue at the top, costs and expenses in between, and net income at the bottom. A cash flow statement tracks the actual cash moving in and out, across operations, investing, and financing. Read together, they show whether reported earnings are backed by real cash.

West Pharmaceutical Services, Inc.
Select Period:
Q1 2026
Total ($)
Q1 2026
Margin (%)
Revenue
844.9m
+146.7m
+21.0%
Gross Income
296.4m
+63.7m
+27.4%
35%
+1.8pp
+5.3%
EBITDA
218.5m
+67.6m
+44.8%
26%
+4.2pp
+19.7%
Operating Income
177.1m
+48.7m
+37.9%
21%
+2.6pp
+14.0%
Net Income
138.8m
+49.0m
+54.6%
16%
+3.6pp
+27.7%
Earnings Per Share
1.93
+0.7
+55.6%
Operating Cash Flow
89.9m
-39.5m
-30.5%
11%
-7.9pp
-42.6%
Free Cash Flow
47.2m
-10.9m
-18.8%
6%
-2.7pp
-32.9%
Research & Development
15.8m
-500.0k
-3.1%
2%
-0.5pp
-19.9%